Alivus Life Sciences Limited has informed the Exchange regarding 'Disclosure under Regulation 30 of SEBI LODR '.
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences has provided an update on the fire incident that occurred on February 14, 2026, at its Dahej manufacturing facility in Bharuch, Gujarat. The fire was confined to just one of the seven production blocks at the site, affecting only a portion of the intermediate manufacturing facilities, while the API manufacturing facilities in the same block remain unaffected. The remaining six production blocks are fully operational. The company expects to resume API production at the affected block from March 1, 2026, and intermediate production from mid-March 2026, noting that a few shipments will be delayed as a result.
The impact appears contained — only 1 of 7 production blocks was affected, API facilities are largely untouched, and 6 blocks continue running normally. Short-term shipment delays are expected, but a recovery timeline of 2-4 weeks limits long-term damage, which is likely positive for the stock given the limited operational disruption.